This is a preview of subscription content, log in via an institution to check access.
Notes
cholesterol ester transfer protein
low density lipoprotein
Reference
Decision Resources. The Dyslipidemia Market Will Grow to $31 Billion in 2022, Driven by the Launch of Novel Therapies. Media Release : 20 Aug 2013. Available from: URL: http://www.decisionresources.com
Rights and permissions
About this article
Cite this article
Dyslipidaemia drug market set to reach $US31 billion by 2022. PharmacoEcon Outcomes News 686, 11 (2013). https://doi.org/10.1007/s40274-013-0698-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0698-6